Skip to main content

Induction of ovulation - for parents-to-be, properly monitored.

If your cycles are irregular or absent, ovulation induction is usually the first - and often the only - fertility treatment needed. Simple tablets restore ovulation in most women with PCOS, and monitored injectable cycles catch most of the rest.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What private ovulation induction costs in the UK.

Indicative ranges across our partner fertility clinics.

In short

£500–£900. Most who conceive do so within 3–6 cycles.

Service Indicative range
Fertility consultation (both partners) £250–£400
Baseline work-up (hormones, AMH, ultrasound, semen analysis) £500–£1,000
Tubal patency check (HyCoSy) £400–£800
Monitored letrozole or clomifene cycle £500–£900
Gonadotrophin injection cycle (drugs included) £1,200–£2,500
Trigger injection and timed IUI add-on £700–£1,200

Costs vary with the drug used, how many scans a cycle needs, and whether intrauterine insemination is added. Gonadotrophin drug doses - and therefore costs - differ between women. NHS funding for ovulation induction exists but varies by area and waiting times are long; many couples use private monitored cycles precisely because timing is everything.

The problem

The right drug, real monitoring, and a plan with an endpoint.

Ovulation induction fails couples in three predictable ways - unmonitored tablets, an incomplete work-up, and cycles that drift on for years. We fix all three.

  • The work-up before the prescription

    Tubes, sperm and hormones checked before cycle one - because inducing ovulation against a blocked tube or an unchecked semen analysis wastes months.

  • Scans, or it did not happen

    Without tracking, nobody knows if you ovulated or how many follicles grew. Monitoring is what makes induction both effective and safe.

  • Six cycles, then a real decision

    The evidence says most who will conceive do so within six ovulatory cycles. We build the review in from day one - no drifting into year two.

When it helps

When ovulation induction is the right step.

The situations we see most, plus the one red flag during treatment that needs same-day review rather than reassurance.

  • PCOS with irregular cycles

    The commonest cause of anovulation. Letrozole restores ovulation in around three-quarters of women with PCOS and is now the recommended first-line drug.

  • Absent periods

    No cycles at all - once the cause is found (PCOS, hypothalamic, prolactin, thyroid), most are treatable and many need only tablets.

  • Cycles too long to work with

    Ovulating four or five times a year quietly halves your chances each year. Induction turns occasional ovulation into monthly opportunity.

  • Hypothalamic anovulation

    Low body weight, intense exercise or stress switching cycles off - needs pulsatile or injectable treatment plus the underlying cause addressed, not clomifene.

  • High prolactin, now treated

    Once a prolactinoma is treated, cycles often return on their own - and respond well to induction when they do not.

  • Clomifene tried, without scans

    Several unmonitored cycles from a GP with no idea whether ovulation ever happened - a situation we inherit weekly, and fix with tracking.

  • Alongside IUI

    For unexplained infertility, a stimulated cycle with intrauterine insemination modestly lifts monthly success - an honest middle step before IVF.

  • Red flag: severe bloating and sickness

    Marked abdominal swelling, vomiting or breathlessness during a stimulated cycle can be ovarian hyperstimulation - same-day clinic review, not a wait-and-see.

Treatment options

Tablets first, injections second, and honesty throughout.

The ladder of ovulation induction - and where IVF genuinely belongs in it.

  • Letrozole

    The evidence-based first choice, especially in PCOS - higher ovulation and live-birth rates than clomifene, with thinner-lining problems less common. Off-label in the UK but guideline-recommended.

  • Clomifene citrate

    The traditional tablet, still effective for many. Limited to about six ovulatory cycles; needs scan monitoring in at least the first cycle to check response.

  • Metformin

    An adjunct in PCOS - modest alone, more useful alongside letrozole or clomifene in insulin-resistant women. Not a fertility drug in its own right.

  • Low-dose gonadotrophin injections

    Daily FSH injections with careful scan monitoring for tablet non-responders - highly effective, with dose creep and multiple follicles the risks the monitoring exists to manage.

  • The hCG trigger

    A single injection maturing and releasing the egg at a chosen time - allowing intercourse or IUI to be timed to the hour rather than guessed.

  • Laparoscopic ovarian drilling

    A keyhole alternative for clomifene-resistant PCOS - restores spontaneous ovulation in around half, without multiple-pregnancy risk. Occasionally the right call.

  • Pulsatile GnRH

  • When IVF is simply the answer

    Blocked tubes, significant male factor, age pressing, or six good ovulatory cycles without conception - we say “move to IVF” the moment the evidence does.

Safety and recovery

What to expect during treatment - honestly.

Ovulation induction is low-risk medicine by fertility standards - provided cycles are monitored. The honest conversation is about twins, hyperstimulation, and knowing when to stop.

  • Side effects of the tablets

    Hot flushes, headaches and mood swings on clomifene; fatigue and dizziness on letrozole - generally mild and limited to the five tablet days.

  • Multiple pregnancy is the main risk

    Twins occur in roughly 5–8% of clomifene conceptions and more with unmonitored injectables. Scan monitoring and strict cancellation rules exist precisely to keep this low.

  • Cycle cancellation is a safety feature

    Frustrating - and much better than a triplet pregnancy.

  • Ovarian hyperstimulation (OHSS)

    Rare with tablets, a genuine risk with gonadotrophins - bloating, sickness and fluid shifts. Low-dose protocols and tracking keep severe OHSS well under 1%.

  • The emotional load

    Monthly cycles of hope and disappointment are heavy.

  • No proven cancer link

    Large studies have not shown that clomifene, letrozole or gonadotrophins increase ovarian or breast cancer risk. Staying within recommended cycle limits is still sensible practice.

  • Letrozole and safety in pregnancy

    Letrozole is taken before ovulation and cleared before implantation; studies show no increase in birth defects versus clomifene or natural conception.

  • Know when to change course

    Six well-monitored ovulatory cycles without pregnancy is the evidence-based point to reassess - more of the same is rarely the answer, and we will say so.

  • Red flags during a cycle

    Severe abdominal pain or swelling, vomiting, breathlessness or reduced urine output during stimulation need same-day clinic contact - never wait for the next scan.

Reading your cycle summary

Your cycle summary in four parts. Read the last one first.

After each monitored cycle, the clinic writes up what happened. The summaries keep to the same shape.

A UK fertility consultant reviewing a patient’s cycle summary

A quiet reminder

Fertility reports are follicle counts and hormone levels - we translate them for you.

If you would like us to talk you through your cycle summary - or a second opinion on whether the plan still makes sense - just ask.

  1. 01 Header

    Diagnosis, drug and dose

    Why you are being treated, which drug and dose this cycle used, and which cycle number this is - context the next decision depends on.

  2. 02 Tracking

    Scans and follicle growth

    Baseline findings, follicle measurements at each visit, and endometrial thickness - the evidence the dose was right or needs changing.

  3. 03 Findings

    Ovulation - confirmed or not

    Trigger timing, the progesterone result or scan confirming release, and whether the cycle was cancelled and why.

  4. 04 Impression

    Next cycle’s plan

    Read this first: the dose for next month, any added tests, how many cycles remain before the strategy review, and your direct contact for the cycle ahead.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Fertility treatment is excluded from most UK private medical insurance policies, so ovulation induction is usually self-funded - though investigations of the underlying cause (PCOS, thyroid, prolactin) are often covered.

Frequently asked

Everything we get asked about ovulation induction.

Quick answers on letrozole vs clomifene, success rates, twins, monitoring, PCOS and cost.

  • What is ovulation induction?

    Medication that prompts the ovary to mature and release an egg in women whose cycles are irregular or absent. Tablets (letrozole or clomifene) are the usual starting point, with low-dose hormone injections for those who need more. Cycles are tracked by ultrasound so intercourse or insemination can be timed - and so the treatment can be kept safe.

  • Letrozole or clomifene - which is better?

    For PCOS, letrozole: head-to-head trials show higher ovulation and live-birth rates, and it is now recommended first-line in UK and international guidance despite being technically off-label for fertility. Clomifene remains a reasonable option and is still widely used. Your consultant will explain the choice - and the reasoning - before prescribing either.

  • What are the chances of success?

    Good, when anovulation is the main problem: around 70–80% of women with PCOS ovulate on letrozole, and 50–70% of ovulating patients conceive within six cycles.

  • Will I have twins?

    The risk is real but manageable: roughly 5–8% of clomifene conceptions are twins, letrozole somewhat lower, and unmonitored injectable cycles are where high-order multiples come from.

  • Why does “parental” or monitored induction need so many scans?

    Two reasons: effectiveness and safety. Tracking shows whether the dose produced a mature follicle - without it, you can swallow tablets for months while never ovulating - and it counts follicles so a cycle can be cancelled before a multiple pregnancy happens. Two or three quick transvaginal scans per cycle is the standard of care, not an upsell.

  • How much does private ovulation induction cost?

    A monitored tablet cycle runs £500–£900 including scans; injectable cycles £1,200–£2,500 with drugs; the initial couple work-up £500–£1,000. Fertility treatment is rarely insurer-funded, so we itemise everything up front - including the drug costs other quotes leave out.